Table 1 Baseline clinical characteristics of the study participants
Total (n = 118) | Group 1 (n = 54) | Group 2 (n = 45) | Group 3 (n = 19) | p-value | |
|---|---|---|---|---|---|
Age (years) | 68 (10) | 68 (10) | 68 (10) | 69 (11) | 0.929 |
Male, n (%) | 34 (50.0) | 23 (56.1) | 11 (40.7) | 11 (40.7) | 0.215 |
Systolic blood pressure (mmHg) | 125 (18) | 128 (18) | 125 (16) | 118 (20) | 0.108 |
Diastolic blood pressure (mmHg) | 69 (11) | 70 (12) | 69 (12) | 66 (9) | 0.349 |
Body surface area (m2) | 1.65 (0.17) | 1.65 (0.16) | 1.67 (0.18) | 1.63 (0.17) | 0.681 |
Baseline creatinine (mg/dL) | 0.93 (0.23) | 0.92 (0.25) | 0.92 (0.20) | 0.95 (0.22) | 0.877 |
Hypertension, n (%) | 68 (57.6) | 33 (61.1) | 25 (55.6) | 10 (52.6) | 0.763 |
Diabetes mellitus, n (%) | 29 (24.6) | 10 (18.5) | 13 (28.9) | 6 (31.6) | 0.364 |
Hyperlipidemia, n (%) | 25 (21.2) | 17 (31.5) | 6 (13.3) | 2 (10.5) | 0.410 |
Current smoker, n (%) | 22 (18.6) | 6 (11.1) | 8 (17.8) | 8 (42.1) | 0.011 |
Atrial fibrillation, n (%) | 10 (8.5) | 5 (9.3) | 2 (4.4) | 3 (15.8) | 0.317 |
Coronary artery disease, n (%)§ | 16 (14.7) | 8 (16.3) | 5 (12.2) | 3 (15.8) | 0.849 |